Hello Avatar! Welcome to another week of biotech analysis. Today’s commentary is as always on Thursday focused on the general market update. For the week XBI was DOWN -2% and remains green at +10% for the year. Understanding how venture capital funds performs is crucial for biotech investors who navigate a landscape where early-stage investments play …
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.